Eurobio Scientific team congress & events
Successful start into 2025
Home » Start into 2025
The group produces reagents and software for transplant matching, chimerism monitoring and culture media for cornea graft transplants.
Eurobio Scientific manufactures prognostic genomic tests for breast cancer and prostate cancer.
The group develops and markets genetic molecular tests to detect a wide variety of illnesses, including detecting infectious diseases, fertility testing or assaying dermatological conditions
To support the research and development field, Eurobio Scientific has a broad portfolio in Life Science products including cell culture media and quality controls.
The controls for auto-immunity and allergy are multi-analyte controls, which offers a the possibility of testing different analytes in parallel by using only one control.
The group produces reagents and software for transplant matching, chimerism monitoring and culture media for cornea graft transplants.
Eurobio Scientific manufactures prognostic genomic tests for breast cancer and prostate cancer.
The group develops and markets genetic molecular tests to detect a wide variety of illnesses, including detecting infectious diseases, fertility testing or assaying dermatological conditions
To support the research and development field, Eurobio Scientific has a broad portfolio in Life Science products including cell culture media and quality controls.
The controls for auto-immunity and allergy are multi-analyte controls, which offers a the possibility of testing different analytes in parallel by using only one control.
The group produces reagents and software for transplant matching, chimerism monitoring and culture media for cornea graft transplants.
Eurobio Scientific manufactures prognostic genomic tests for breast cancer and prostate cancer.
The group develops and markets genetic molecular tests to detect a wide variety of illnesses, including detecting infectious diseases, fertility testing or assaying dermatological conditions
To support the research and development field, Eurobio Scientific has a broad portfolio in Life Science products including cell culture media and quality controls.
The controls for auto-immunity and allergy are multi-analyte controls, which offers a the possibility of testing different analytes in parallel by using only one control.
Eurobio Scientific team congress & events
Home » Start into 2025
This Privacy Policy informs you about the manner in which Eurobio Scientific collects and processes personal data concerning you via its website www.eurobio-scientific.com (hereinafter the Website) as data controller within the meaning of the provisions of the General Data Protection Regulation No. 2016/679 of 27 April 2016 (“GDPR”) and the Data Protection Act No. 78-17 of 6 January 1978 (hereinafter together referred to as the “Regulations”).
All Eurobio Scientific Group affiliates gathered at the headquarters in France for this year’s strategy session, where the management team:
✅ Reflected on the achievements and challenges of the past year
✅ Determined goals for 2025
✅ Got great inspiration at the kick-off party in Domaine de la Voisine
We are excited for 2025 and look forward to driving innovation and achieving our ambitious goals together❗
Eurobio Scientific, Eurobio Scientific UK, eurobiodid, TECOmedical AG, GenDx, Eurobio Oncology, Biomedical Diagnostics
#EurobioScientificGroup #Transplantation #Infectiousdiseases #Lifesciences #Oncology